International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

654.00p

Buy

668.00p

arrow-up1.66p (+0.25%)

Discount/Premium

-10.41%

Estimated NAV

738.94p

Prices updated at 25 Mar 2025, 10:04 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

FTSE All-Share

0.42%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual performance (%)

Year chevron-l-regular chevron-r-regular	This fund	Peer group index
31 Dec 14 - 31 Dec 15	22.18	11.54
31 Dec 15 - 31 Dec 16	1.62	-2.24
31 Dec 16 - 31 Dec 17	18.27	3.89
31 Dec 17 - 31 Dec 18	-2.52	-11.07
31 Dec 18 - 31 Dec 19	13.69	53.71
31 Dec 19 - 31 Dec 20	35.64	38.69
31 Dec 20 - 31 Dec 21	-4.76	1.03
31 Dec 21 - 31 Dec 22	-1.54	-12.63
31 Dec 22 - 31 Dec 23	-4.89	-0.57
31 Dec 23 - 31 Dec 24	10.93	-4.10

Primary benchmark: Nasdaq Biotechnology Index

Peer group index: Morningstar IT Biotechnology & Healthcare

Trailing returns (%)

Year chevron-l-regular chevron-r-regular	This fund	Peer group index
1 Day	1.53	0.64
1 Month	-7.02	-7.63
3 Months	-3.22	-6.96
6 Months	-0.40	-16.43
1 Year	5.06	-16.22
3 Years annualised	5.69	-3.95
5 Years annualised	9.23	3.76

Primary benchmark: Nasdaq Biotechnology Index

Peer group index: Morningstar IT Biotechnology & Healthcare

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.